Hepatitis C In Drug And Alcohol Settings

Hosted by the Victorian HIV and Hepatitis Integrated Training and Learning program, this course aims to provide addiction physicians, general practitioners, nurse practitioners, and other practitioners working in Drug and Alcohol settings with the skills and knowledge to diagnose HCV, manage comorbidities and treat HCV.

Date: Thursday, 8 June 2023

Time: 6:00-9:00pm (AEST)

Facilitator: 

• Dr Matt Penn, GP at North Richmond Community Health
• Dr Tim Papaluca, Gastroenterologist at St. Vincent's Hospital

Target Audience

Addiction medicine physicians, general practitioners, nurse practitioners, and other practitioners prescribing or intending to prescribe s85 DAA medication in alcohol and other drug settings (open also to those working in primary care settings).

Learning Outcomes

• Describe risk factors for HCV, enabling discussions with clients around prevention and harm reduction

• Screen, order and interpret tests appropriately to diagnose chronic HCV infection

• Describe the recommended pre-treatment assessment, including liver disease staging

• Determine the appropriate antiviral therapy for the treatment of HCV and explain treatment to the patient

• Implement monitoring and post-treatment follow-up recommendations

RACGP: This course is endorsed by the ACN according to our CPD endorsed course standards. Due to the transition to the new RACGP triennium, this activity’s accreditation is pending. Participants will need to self-record this activity via Quick Log through their RACGP myCPD dashboard. Your Statement of Attendance will include a breakdown of hours and activity types.